Lilly(Eli) & Co

NYSE:LLY   3:59:59 PM EDT
286.28
-8.91 (-3.02%)
Products

Innovent Biologics Says U.S. FDA Issued Complete Response Letter For Application For Sintilimab Injection

Published: 03/24/2022 14:16 GMT
Lilly(Eli) & Co (LLY) - U.S. FDA Issued a Complete Response Letter for Biologics License Application for Sintilimab Injection.
FDA is Unable to Approve Application in Its Current Form.
Co and Eli Lilly Assessing Next Steps for Sintilimab Program in U.S.